Position in ENTA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$26,231
+$3,807 QoQ
Shares Held
2,077
+46.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,808,560 across 402 Biotechnology names. ENTA ranks #254 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,231 | 2,077 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $22,424 | 1,422 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $25,160 | 2,102 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $70,624 | 9,342 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $80,414 | 14,568 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $89,279 | 15,527 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $152,053 | 14,677 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $59,116 | 4,558 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $66,767 | 3,824 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $26,658 | 2,833 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $6,109 | 547 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $860,922 | 40,230 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $2,038,983 | 50,420 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,259,010 | 48,560 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $3,640,962 | 70,194 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,108,001 | 65,750 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $2,028,701 | 28,501 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $3,985,624 | 53,298 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,511,543 | 26,607 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $2,114,592 | 48,048 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,062,179 | 62,088 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,169,707 | 51,537 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,328,736 | 50,868 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,083,933 | 21,588 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $862,428 | 16,769 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||